Investigations on the acute toxicity of acidic and basic triamterene derivatives. 1995

H Priewer, and E Wolf, and F Ullrich, and T Netzer, and G Vollmer, and E Mutschler
Department of Pharmacology, Faculty of Biochemistry, Pharmacy and Food Chemistry, University of Frankfurt.

Acidic and basic triamterene derivatives were evaluated with respect to their acute toxicity. After single intravenous application in mice, derivatives with a basic side-chain were much more toxic than compounds with an acidic side-chain. There is a significant correlation between the potassium retaining properties (measured as ED50) and the acute toxicity (measured as LD50) of the substances. The low acute toxicity after oral application of the compounds can be explained by their low oral bioavailability.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D008297 Male Males
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014223 Triamterene A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS. Dyrenium,Dytac,Urocaudal
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

H Priewer, and E Wolf, and F Ullrich, and T Netzer, and G Vollmer, and E Mutschler
April 1986, Pharmaceutical research,
H Priewer, and E Wolf, and F Ullrich, and T Netzer, and G Vollmer, and E Mutschler
January 1985, Arzneimittel-Forschung,
H Priewer, and E Wolf, and F Ullrich, and T Netzer, and G Vollmer, and E Mutschler
February 1986, Arzneimittel-Forschung,
H Priewer, and E Wolf, and F Ullrich, and T Netzer, and G Vollmer, and E Mutschler
March 1985, Pharmaceutical research,
H Priewer, and E Wolf, and F Ullrich, and T Netzer, and G Vollmer, and E Mutschler
January 1963, Acta pharmacologica et toxicologica,
H Priewer, and E Wolf, and F Ullrich, and T Netzer, and G Vollmer, and E Mutschler
August 1989, Plant physiology,
H Priewer, and E Wolf, and F Ullrich, and T Netzer, and G Vollmer, and E Mutschler
January 1985, Arzneimittel-Forschung,
H Priewer, and E Wolf, and F Ullrich, and T Netzer, and G Vollmer, and E Mutschler
March 1997, Die Pharmazie,
H Priewer, and E Wolf, and F Ullrich, and T Netzer, and G Vollmer, and E Mutschler
August 2000, Journal of chromatography. A,
H Priewer, and E Wolf, and F Ullrich, and T Netzer, and G Vollmer, and E Mutschler
May 2000, Biochemical and biophysical research communications,
Copied contents to your clipboard!